FindTrial
Sign In

Vitamin C to reduce complications in born too early babies.

Study Of Ascorbic acid supplementation In reducing morbidities in preterm neonates A Randomized open label Interventional Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079512
Enrollment
130
Registered
2025-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P073- Preterm [premature] newborn [other]

Interventions

Intervention1: Vitamin-C kid Syrup: 40 mg/kg Body Weight Once daily Administered orally or through Ryles tube upto 7 days Control Intervention1: Control Group: Without Vitamin C Supplementation.

Sponsors

BLDE Deemed to be University Shri B M Patil Medical College Hospital and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: gestational age less than 37 weeks birth weight less than 2.5 kg stable babies on oral or NG tube feeds

Exclusion criteria

Exclusion criteria: congenital ,chromosomal anomalies. critically sick babies known inborn errors of metabolism.

Design outcomes

Primary

MeasureTime frame
Duration of NICU stayTimepoint: one or two weeks—

Secondary

MeasureTime frame
ROP NEC and IVH RDSTimepoint: two weeks—

Countries

India

Contacts

Public ContactM P Sri Hira

BLDE Deemed Shri B M Patil Medical College Hospital and Research Centre

rhgobbur@gmail.com9449575922

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026